Status:
COMPLETED
Early Detection of GEnetic Risk (EDGE)
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Genetic Predisposition
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary canc...
Detailed Description
Current practice guidelines from ACMG (American College of Medical Genetics and Genomics) provide referral indications for cancer predisposition assessment. Identifying patients with high genetic risk...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Patients:
- Age 25 or older
- An active patient at a participating clinic (had at least one visit in the past 12 months)
- Comfortable reading and writing in English
- Exclusion Criteria:
- Those who do not meet inclusion criteria.
Exclusion
Key Trial Info
Start Date :
September 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
20184 Patients enrolled
Trial Details
Trial ID
NCT04746794
Start Date
September 25 2020
End Date
June 1 2023
Last Update
October 9 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Billings Clinic
Billings, Montana, United States, 59101
2
MultiCare Health System
Tacoma, Washington, United States, 98405